Infections associated with immunologic deficiency diseases.
D058186:Acute Kidney Injury / Q000150:complications; D000328:Adult; D000361:Agammaglobulinemia / Q000150:complications / Q000151:congenital; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D001228:Aspergillosis / Q000209:etiology; D001424:Bacterial Infections / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D002177:Candidiasis / Q000209:etiology; D002648:Child; D005260:Female; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D006967:Hypersensitivity; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007249:Inflammation; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D008231:Lymphopenia / Q000150:complications / Q000151:congenital; D008297:Male; D011008:Pneumococcal Infections / Q000209:etiology; D011010:Pneumocystis; D011241:Prednisone / Q000009:adverse effects; D018805:Sepsis / Q000209:etiology; D013950:Thymus Gland / Q000002:abnormalities; D014123:Toxoplasmosis / Q000209:etiology; D014184:Transplantation, Homologous / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D011241:Prednisone